Safety profile of enfortumab vedotin plus pembrolizumab in locally advanced or metastatic urothelial carcinoma: a multicenter Japanese cohort study
Kosuke Iwatani(Jikei University School of Medicine), Takahiro Kimura(Jikei University School of Medicine), Fumihiko Urabe(Jikei University School of Medicine), Kensuke Fujiwara(Nagano Municipal Hospital), Wataru Fukuokaya(Jikei University School of Medicine), Jun Miki(Jikei University School of Medicine), Shunsuke Tsuzuki(Jikei University School of Medicine), Shun Saito(Jikei University School of Medicine), Keiichiro Mori(Jikei University School of Medicine), Masaya Murakami(Jikei University School of Medicine), Takafumi Yanagisawa(Jikei University School of Medicine), Kojiro Tashiro(Jikei University School of Medicine), Kanako Kasai(Jikei University School of Medicine), Sotaro Kayano(Jikei University Kashiwa hospital), Shuhei Hara(Jikei University School of Medicine), Shota Kawano(Jikei University School of Medicine), Yu Imai(Jikei University School of Medicine), Mimu Ishikawa(Jikei University School of Medicine), Juria Nakano(Jikei University School of Medicine), Yuma Waki(Jikei University Kashiwa hospital)
Cited by 4
Related Papers
Extracellular vesicles as biomarkers and therapeutic targets for cancer
|American Journal of Physiology-Cell Physiology|2019|412
Circulating miRNA panels for specific and early detection in bladder cancer
|Cancer Science|2018|282
Large-scale Circulating microRNA Profiling for the Liquid Biopsy of Prostate Cancer
|Clinical Cancer Research|2019|129
Exploiting the message from cancer: the diagnostic value of extracellular vesicles for clinical applications
|Experimental & Molecular Medicine|2019|112
Extracellular vesicles in the development of organ‐specific metastasis
|Journal of Extracellular Vesicles|2021|101